Renal Failure · 2018 · 30 citations · 30 references
MedicineNephrologyDialysisHemodialysisRenal Replacement TherapyCardiovascular DiseaseChronic Kidney DiseaseRenal DiseaseRenal Function TestsRenal NutritionB-type Natriuretic PeptidesCardiothoracic RatioCardiovascular Disease IncidenceCardiovascular Disease MortalityCardiovascular Risk In HemodialysisPredictive Marker AssessmentPrognostic Prediction ModelsSystolic Blood Pressure
N-terminal-pro-B-type-natriuretic peptide (NT-proBNP) was a predictive marker of cardiovascular disease (CVD)-related death in chronic dialysis patients. NT-proBNP was also correlated with markers of inflammation, malnutrition and protein-energy wasting. We hypothesized whether NT-proBNP was also associated with non-CVD death in chronic dialysis patients. A prospective observational study for incidence of death in chronic dialysis patients was conducted. Prevalent chronic dialysis patients (n = 1310) were enrolled and followed for 24 months. One hundred forty-four deaths were recorded. Area under the curve using ROC analysis for NT-proBNP showed: all causes of death (0.761), CVD-related (0.750), infection and malignancy-related (0.702) and others and unknown (0.745). After adjusting for age, sex, hemodialysis vintage, cardiothoracic ratio, mean pre-dialysis systolic blood pressure, dry weight and basal kidney disease, the hazard ratios (95% confidence intervals) per 1-log NT-proBNP calculated using multivariate Cox analysis were: all causes of death, 3.83 (2.51-5.85); CVD-related, 4.30 (2.12-8.75); infection and malignancy-related, 2.41 (1.17-4.93); and others and unknown origin, 5.63 (2.57-12.37). NT-proBNP was significantly associated not only with CVD-relate but also with non-CVD-related deaths in this population of prevalent chronic dialysis patients.
30
Marlies Antlanger, Stefan Aschauer, Chantal Kopecky et al. · Kidney & Blood Pressure Research · 2017 · 2.8K citations · Full text
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
Josef Zimmermann, Silke Herrlinger, Antje Pruy et al. · Kidney International · 1999 · 1.5K citations
Medicine, Immunology, Nephrology +14
David A. Morrow, Christopher P. Cannon, Robert L. Jesse et al. · Circulation · 2007 · 611 citations